aspirin has been researched along with sr26334 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Di, Y; Guo, T; Hou, J; Kong, F; Li, Y; Ming, JE; Ping, C; Wang, L; Xie, F; Yang, N; Yin, H; Zhang, L | 1 |
Du, Y; Li, L; Li, X; Lv, Y; Tan, J; Zhai, X | 1 |
1 trial(s) available for aspirin and sr26334
Article | Year |
---|---|
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized
Topics: Acute Coronary Syndrome; Adult; Area Under Curve; Asian People; Aspirin; Clopidogrel; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Male; Therapeutic Equivalency; Thrombosis; Ticlopidine | 2020 |
1 other study(ies) available for aspirin and sr26334
Article | Year |
---|---|
A pharmacokinetics interaction study of antiplatelet agents aspirin and clopidogrel combined with dl-3-n-butylphthalide in rats by liquid chromatography-tandem mass spectrometry.
Topics: Animals; Aspirin; Chromatography, High Pressure Liquid; Chromatography, Liquid; Clopidogrel; Platelet Aggregation Inhibitors; Rats; Salicylic Acid; Tandem Mass Spectrometry | 2023 |